BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang R, Liu X. Epigenetic regulation of prostate cancer. Genes Dis 2020;7:606-13. [PMID: 33335960 DOI: 10.1016/j.gendis.2019.10.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Rocha SM, Sousa I, Gomes IM, Arinto P, Costa-Pinheiro P, Coutinho E, Santos CR, Jerónimo C, Lemos MC, Passarinha LA, Socorro S, Maia CJ. Promoter Demethylation Upregulates STEAP1 Gene Expression in Human Prostate Cancer: In Vitro and In Silico Analysis. Life (Basel) 2021;11:1251. [PMID: 34833128 DOI: 10.3390/life11111251] [Reference Citation Analysis]
2 Ye M, Gao R, Chen S, Wei M, Wang J, Zhang B, Wu S, Xu Y, Wu P, Chen X, Ma J, Ma D, Dong K. Downregulation of MEG3 and upregulation of EZH2 cooperatively promote neuroblastoma progression. J Cell Mol Med 2022. [PMID: 35257481 DOI: 10.1111/jcmm.17258] [Reference Citation Analysis]
3 Li M, Yu X, Zheng Q, Zhang Q, He Y, Guo W. Promising role of long non-coding RNA PCAT6 in malignancies. Biomed Pharmacother 2021;137:111402. [PMID: 33761616 DOI: 10.1016/j.biopha.2021.111402] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Cao Y, Chai W, Wang Y, Tang D, Shao D, Song H, Long J. lncRNA TUG1 inhibits the cancer stem cell‑like properties of temozolomide‑resistant glioma cells by interacting with EZH2. Mol Med Rep 2021;24:533. [PMID: 34036375 DOI: 10.3892/mmr.2021.12172] [Reference Citation Analysis]